Orthostatic Therapy Demand The VM-100 Hummingbird device targets orthostatic hypotension symptoms linked to fibromyalgia and chronic fatigue syndrome, indicating a potential market among patients with low blood pressure after standing or sitting and the need for non-invasive muscle-stimulation therapies.

Early Access Advantage Offer a 30 day free trial to healthcare providers and patients to drive adoption, gather real-world usage data, and demonstrate efficacy before purchase, reducing friction in procurement for clinics and care facilities.

Clinical Education Play Position Vital Motion as an educational partner by supplying clinician-facing materials that explain soleus muscle function and orthostatic issues, enabling CPT/CCM programs and physiatry practices to incorporate VM-100 into treatment protocols.

Small Biz Agility With a lean team and revenue under one million, target niche specialty clinics, rehabilitation centers, and wellness clinics focusing on FM, CFS, and autonomic dysfunction to maximize ROI and scale through partnerships.

Strategic Partnerships Explore collaborations with medical device distributors, orthopedic and physiatry networks, and research institutions conducting fibromyalgia and orthostatic research to expand sales channels and validate clinical outcomes.